LEMBOREXANT - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2020-06-05
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:18:59
Label at a glance#
ProductLEMBOREXANT
Active ingredientLEMBOREXANT
Products#
Every source-derived product name is available through these pages.
- LEMBOREXANT
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LEMBOREXANT | 0K5743G68X | ACTIB |
| LEMBOREXANT | 0K5743G68X | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAYVIGO | LEMBOREXANT | Eisai Inc. | 7074cb65-77b3-45d2-8e8d-da8dc0f70bfd | 2025-02-24 | Warnings, Adverse reactions | LEMBOREXANT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.